X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (80055) 80055
Newsletter (689) 689
Magazine Article (288) 288
Book Chapter (233) 233
Newspaper Article (147) 147
Dissertation (105) 105
Conference Proceeding (70) 70
Book / eBook (58) 58
Publication (36) 36
Reference (20) 20
Book Review (14) 14
Government Document (8) 8
Web Resource (8) 8
Streaming Video (5) 5
Journal / eJournal (4) 4
Transcript (4) 4
Paper (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (41823) 41823
humans (30876) 30876
male (25224) 25224
calcium channel blockers - pharmacology (20789) 20789
rats (18850) 18850
calcium - metabolism (17052) 17052
female (15617) 15617
calcium (14408) 14408
calcium channel blockers - therapeutic use (12369) 12369
pharmacology & pharmacy (11800) 11800
neurosciences (10860) 10860
in vitro techniques (8931) 8931
physiology (8899) 8899
mice (7959) 7959
calcium channels (7888) 7888
middle aged (7793) 7793
cells, cultured (7326) 7326
dose-response relationship, drug (6306) 6306
hypertension - drug therapy (6248) 6248
aged (6042) 6042
adult (6024) 6024
rats, sprague-dawley (5699) 5699
biochemistry & molecular biology (5641) 5641
hypertension (5640) 5640
cell biology (5410) 5410
cardiac & cardiovascular systems (5287) 5287
calcium channel blockers (5249) 5249
patch-clamp techniques (5114) 5114
nifedipine - pharmacology (4785) 4785
rats, wistar (4719) 4719
neurons (4420) 4420
time factors (4308) 4308
blood pressure - drug effects (4250) 4250
cells (4193) 4193
membrane potentials - drug effects (3917) 3917
research (3866) 3866
activation (3845) 3845
verapamil - pharmacology (3832) 3832
channels (3776) 3776
nifedipine (3761) 3761
electrophysiology (3759) 3759
calcium channels - metabolism (3745) 3745
peripheral vascular disease (3544) 3544
antihypertensive agents - therapeutic use (3511) 3511
calcium channel blockers - administration & dosage (3430) 3430
expression (3394) 3394
inhibition (3292) 3292
calcium - physiology (3249) 3249
physiological aspects (3180) 3180
kinetics (3157) 3157
neurons - drug effects (3155) 3155
calcium channels - drug effects (3153) 3153
proteins (3004) 3004
analysis (2996) 2996
calcium channel blockers - adverse effects (2966) 2966
calcium channels - physiology (2926) 2926
rabbits (2863) 2863
verapamil (2858) 2858
rat (2795) 2795
research article (2794) 2794
calcium-channel blockers (2783) 2783
rodents (2782) 2782
adrenergic beta-antagonists - therapeutic use (2754) 2754
potassium channels (2659) 2659
guinea pigs (2645) 2645
cell line (2644) 2644
signal transduction (2626) 2626
angiotensin-converting enzyme inhibitors - therapeutic use (2610) 2610
treatment outcome (2591) 2591
calcium - pharmacology (2590) 2590
neurons - metabolism (2575) 2575
enzyme inhibitors - pharmacology (2574) 2574
ion channels (2546) 2546
membrane potentials - physiology (2534) 2534
risk factors (2494) 2494
multidisciplinary sciences (2476) 2476
hypertension - physiopathology (2413) 2413
drug therapy, combination (2409) 2409
muscle, smooth, vascular - drug effects (2339) 2339
muscle contraction - drug effects (2300) 2300
release (2264) 2264
action potentials - drug effects (2226) 2226
brain (2213) 2213
neurons - physiology (2210) 2210
apoptosis (2180) 2180
ca2+ channels (2153) 2153
calcium signaling - drug effects (2139) 2139
receptors (2108) 2108
phosphorylation (2098) 2098
electric stimulation (2071) 2071
heart (2065) 2065
drug interactions (2005) 2005
medicine, general & internal (1983) 1983
blood pressure (1979) 1979
dogs (1971) 1971
myocardium - metabolism (1953) 1953
disease models, animal (1949) 1949
mechanisms (1929) 1929
heart rate - drug effects (1928) 1928
mice, inbred c57bl (1901) 1901
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (55) 55
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Theses (1) 1
Providence Healthcare - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (77470) 77470
Japanese (1426) 1426
Russian (879) 879
German (796) 796
French (632) 632
Chinese (527) 527
Spanish (349) 349
Italian (228) 228
Polish (152) 152
Portuguese (82) 82
Ukrainian (71) 71
Dutch (64) 64
Korean (57) 57
Swedish (57) 57
Czech (56) 56
Hungarian (49) 49
Danish (37) 37
Norwegian (35) 35
Slovak (29) 29
Finnish (25) 25
Turkish (25) 25
Romanian (20) 20
Hebrew (18) 18
Bulgarian (12) 12
Serbian (11) 11
Croatian (10) 10
Lithuanian (6) 6
Bosnian (4) 4
Persian (4) 4
Slovenian (2) 2
Arabic (1) 1
Belarusian (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet neurology, ISSN 1474-4422, 2010, Volume 9, Issue 5, pp. 469 - 480
Journal Article
The journal of clinical hypertension (Greenwich, Conn.), ISSN 1524-6175, 2011, Volume 13, Issue 9, pp. 687 - 689
Journal Article
Journal Article
Hypertension, ISSN 0194-911X, 06/2012, Volume 59, Issue 6, pp. 1132 - 1138
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 04/2013, Volume 20, Issue 10, pp. 1241 - 1285
... are: sleep disorders, anxiety, epilepsy, pain, etc. However, traditional channel blockers have multiple adverse events, mainly due to low specificity of mechanism of action... 
ASIC | TRP | Central nervous system | P2X | KCNQ | NMDA | CNS | Ion channels | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | GATED SODIUM-CHANNELS | SUBTYPE-SELECTIVE AGONIST | D-ASPARTATE RECEPTOR | ion channels | ACID-SENSING ION-CHANNEL-1 | central nervous system | GLYCINE ANTAGONIST GV150526 | TARANTULA TOXIN PSALMOTOXIN-1 | TRAUMATIC BRAIN-INJURY | ISCHEMIC CELL-DEATH | PHARMACOLOGY & PHARMACY | PERIPHERAL NEUROPATHIC PAIN | TRANSGENIC MOUSE MODEL | Ligand-Gated Ion Channels - antagonists & inhibitors | Transient Receptor Potential Channels - antagonists & inhibitors | Calcium Channels - metabolism | Humans | Calcium Channel Blockers - therapeutic use | Potassium Channel Blockers - therapeutic use | Sodium Channel Blockers - pharmacology | Calcium Channel Blockers - pharmacology | Ion Channels - antagonists & inhibitors | Potassium Channels - metabolism | Animals | Ion Channels - metabolism | Sodium Channels - chemistry | Calcium Channels - chemistry | Central Nervous System Diseases - drug therapy | Sodium Channels - metabolism | Calcium Channel Blockers - chemistry | Sodium Channel Blockers - therapeutic use | Potassium Channels - chemistry | Sodium Channel Blockers - chemistry | Transient Receptor Potential Channels - metabolism | Ligand-Gated Ion Channels - metabolism | Potassium Channel Blockers - chemistry | Potassium Channel Blockers - pharmacology
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2017, Volume 2017, Issue 1, p. CD002003
Background Beta‐blockers refer to a mixed group of drugs with diverse pharmacodynamic and pharmacokinetic properties... 
Hypertension | Kidney disease | Treatment: pharmacological | Stroke | Angiotensin Receptor Antagonists | Pharmacological Therapies | Heart Arrest | Atenolol | Randomized Controlled Trials as Topic | General Pharmacotherapies | Calcium Channel Blockers | Coronary Disease | Adrenergic beta‐Antagonists | Diuretics | Beta‐adrenergic blocking agents | Antihypertensive Agents | Heart & circulation | Medicine General & Introductory Medical Sciences | Treatment of essential Hypertension | Angiotensin Receptor Antagonists [therapeutic use] | Antihypertensive Agents [adverse effects; therapeutic use] | NITRIC-OXIDE RELEASE | Humans | Middle Aged | Calcium Channel Blockers [therapeutic use] | MEDICINE, GENERAL & INTERNAL | END-POINT REDUCTION | Adult | CENTRAL BLOOD-PRESSURE | Hypertension [drug therapy; mortality] | ANTIHYPERTENSIVE TREATMENT | Heart Arrest [prevention & control] | CHRONIC HEART-FAILURE | Diuretics [therapeutic use] | Coronary Disease [prevention & control] | RANDOMIZED-TRIAL | CARDIOVASCULAR MORBIDITY | CALCIUM-CHANNEL BLOCKERS | DIRECT RENIN INHIBITOR | Atenolol [therapeutic use] | Aged | Stroke [prevention & control] | Adrenergic beta-Antagonists [adverse effects; therapeutic use] | CORONARY-ARTERY-DISEASE | Stroke - prevention & control | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Atenolol - therapeutic use | Heart Arrest - prevention & control | Adrenergic beta-Antagonists - adverse effects | Diuretics - therapeutic use | Hypertension - mortality | Angiotensin Receptor Antagonists - therapeutic use | Adrenergic beta-Antagonists - therapeutic use
Journal Article
Frontiers in pharmacology, ISSN 1663-9812, 2017, Volume 8, Issue MAY, p. 286
Journal Article